Melphalan

ADVERTISEMENT

Identification

Molecular formula
C13H18Cl2N2O2
CAS Number
148-82-3
IUPAC Name
2-amino-N-[4-[bis(2-chloroethyl)amino]phenyl]acetamide
Molecular Weight
305.20g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.6460g/cm3
Interesting facts

Interesting Facts about 2-amino-N-[4-[bis(2-chloroethyl)amino]phenyl]acetamide

2-amino-N-[4-[bis(2-chloroethyl)amino]phenyl]acetamide is a fascinating compound that serves as an important example in the field of medicinal chemistry. Below are some intriguing aspects of this compound:

  • Anticancer Research: This compound is a derivative of the well-known alkylating agent chlorambucil, which has shown efficacy in treating certain types of cancers. Researchers are continually studying its mechanism and potential therapeutic uses in oncology.
  • Mechanism of Action: The compound’s structure allows it to form DNA cross-links, which is crucial to its ability to inhibit cancer cell proliferation. It interacts with cellular processes, making it a target of interest for developing new cancer therapies.
  • Structure-Activity Relationship (SAR): Chemists analyze the compound's various functional groups and their contributions to its biological activity. This study helps in designing more effective analogs while minimizing side effects.
  • Toxicity Concerns: The presence of chlorinated ethyl groups raises concerns regarding its cytotoxicity. Understanding the relationship between structure and toxicity can guide the development of safer derivatives.
  • Research Opportunities: This compound serves as a valuable research template for medicinal chemists aiming to synthesize novel agents with improved selectivity for cancer cells, possibly leading to fewer side effects than existing treatments.

In summary, 2-amino-N-[4-[bis(2-chloroethyl)amino]phenyl]acetamide continues to attract attention for its potential application in cancer treatment and its role as a pivotal compound in ongoing pharmaceutical research. As scientists delve deeper into its properties and interactions, it may pave the way for advancements in targeted cancer therapies.

ADVERTISEMENT